Ending chemotherapy induced hair loss.
Ending chemotherapy induced hair loss.
47% OF PATIENTS SAY HAIR LOSS IS THE MOST TRAUMATIC PART OF CANCER TREATMENT.
Luminate Medical has developed a novel device to prevent hair loss during chemotherapy. The unique portable, comfortable and wearable solution allows patients to maintain their confidence and dignity during treatment.
Hair loss is one of the most well recognised side effects of chemotherapy, affecting millions of cancer patients annually. Luminate Medical is dedicated to providing a patient-focused alternative.
News
%20Jason%20Costello%2C%20Barbara%20Oliveira%2C%20Brendan%20Divilly%20and%20Aaron%20Hannon_PNG.png)
December 2nd, 2021
Emerging MedTech Company of the Year
Luminate Medical has been named the Emerging MedTech Company of the Year at the 2021 Medtech Rising Conference...
June 20, 2021
EIT Health Catapult Semi Finalists Announced
Forty-two start-ups have selected from across Europe for the EIT Health Catapult Semi-finals. The start-ups will receive intensive training from...
August 30, 2021
Luminate aims to make hair loss a thing of the past
Hair loss resulting from chemotherapy is one of the most recognizable side effects in all of medicine, and for many is an unwanted public announcement..
February 18, 2021
A solution to chemo hair loss and more innovations
Covid may have ramped up the challenges of getting a new business going, but it hasn’t dampened the drive of five young entrepreneurs...
June 26, 2021
Luminate Medical joins Y Combinator S21 Batch
Luminate Medical has received the backing of world-renowned technology accelerator Y Combinator to continue developing its novel...
December 31, 2020
Hannon announced as Thiel Fellowship recipient
The Thiel Foundation today named 24 people into the 2020 class of Thiel Fellows. The Fellowship program, which launched in 2011, encourages...